February 12, 2019
Mochida Pharmaceutical said on February 8 that it has filed an application in Japan seeking an additional indication for Dinagest (dienogest) for the treatment of dysmenorrhea. Dinagest, which was licensed from Germany’s Jenapharm, now under the Bayer AG group, hit...read more